148 related articles for article (PubMed ID: 31523973)
1. A pediatric case of NF1 and moyamoya syndrome: Neuropsychological evaluation pre- and post-EDAS.
DeDios-Stern S; Ventura LM
Appl Neuropsychol Child; 2021; 10(3):283-296. PubMed ID: 31523973
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
[TBL] [Abstract][Full Text] [Related]
3. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
[TBL] [Abstract][Full Text] [Related]
4. Moyamoya syndrome and neurofibromatosis type 1.
Vargiami E; Sapountzi E; Samakovitis D; Batzios S; Kyriazi M; Anastasiou A; Zafeiriou DI
Ital J Pediatr; 2014 Jun; 40():59. PubMed ID: 24952383
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and long-term outcomes of moyamoya syndrome associated with neurofibromatosis type 1.
Han C; Yang WZ; Zhang HT; Ye T; Duan L
J Clin Neurosci; 2015 Feb; 22(2):286-90. PubMed ID: 25443089
[TBL] [Abstract][Full Text] [Related]
6. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
[TBL] [Abstract][Full Text] [Related]
7. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
Hyman SL; Shores A; North KN
Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis type 1 associated with moyamoya syndrome. Case report and review of the literature.
Budişteanu M; Burloiu CM; Papuc SM; Focşa IO; Riga D; Riga S; Arghir A
Rom J Morphol Embryol; 2019; 60(2):713-716. PubMed ID: 31658349
[TBL] [Abstract][Full Text] [Related]
9. Management of glioblastoma in an NF1 patient with moyamoya syndrome: a case report.
Arita H; Narita Y; Ohno M; Miyakita Y; Okita Y; Ide T; Shibui S
Childs Nerv Syst; 2013 Feb; 29(2):341-5. PubMed ID: 23108917
[TBL] [Abstract][Full Text] [Related]
10. Scoliosis Secondary to Neurofibromatosis Type I Combined With Moyamoya Syndrome: A Case Report.
Zhang H; Luo Y; Guo D; Yao Z; Liu H; Zhang X
JBJS Case Connect; 2022 Jul; 12(3):. PubMed ID: 36137072
[TBL] [Abstract][Full Text] [Related]
11. Specific learning disorder in mathematics and moyamoya disease: A case report.
Mikula C; Kim JH; Phenis R; Kiselica A
Appl Neuropsychol Child; 2023; 12(2):157-164. PubMed ID: 35138968
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological factors associated with performance on the rey-osterrieth complex figure test in children with neurofibromatosis type 1.
Maier A; Pride NA; Hearps SJC; Shah N; Porter M; North KN; Payne JM
Child Neuropsychol; 2024 Feb; 30(2):348-359. PubMed ID: 37038321
[TBL] [Abstract][Full Text] [Related]
13. Does attention-deficit-hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1?
Payne JM; Arnold SS; Pride NA; North KN
Dev Med Child Neurol; 2012 Oct; 54(10):898-904. PubMed ID: 22845611
[TBL] [Abstract][Full Text] [Related]
14. Executive dysfunction in children with neurofibromatosis type 1: a study of action planning.
Roy A; Roulin JL; Charbonnier V; Allain P; Fasotti L; Barbarot S; Stalder JF; Terrien A; Le Gall D
J Int Neuropsychol Soc; 2010 Nov; 16(6):1056-63. PubMed ID: 20682087
[TBL] [Abstract][Full Text] [Related]
15. Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience.
Santoro C; Di Rocco F; Kossorotoff M; Zerah M; Boddaert N; Calmon R; Vidaud D; Cirillo M; Cinalli G; Mirone G; Giugliano T; Piluso G; D'Amico A; Capra V; Pavanello M; Cama A; Nobili B; Lyonnet S; Perrotta S
Am J Med Genet A; 2017 Jun; 173(6):1521-1530. PubMed ID: 28422438
[TBL] [Abstract][Full Text] [Related]
16. 'Moya' than meets the eye: neurofibromatosis type 1 associated with Moyamoya syndrome.
Tan RM; Chng SM; Seow WT; Wong J; Lim CC
Singapore Med J; 2008 Apr; 49(4):e107-9. PubMed ID: 18418511
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological impacts of indirect revascularization for pediatric moyamoya disease.
Kim W; Lee EY; Park SE; Park EK; Kim JS; Kim DS; Shim KW
Childs Nerv Syst; 2018 Jun; 34(6):1199-1206. PubMed ID: 29679197
[TBL] [Abstract][Full Text] [Related]
18. Adaptive functioning in children with neurofibromatosis type 1: relationship to cognition, behavior, and magnetic resonance imaging.
Eby NS; Griffith JL; Gutmann DH; Morris SM
Dev Med Child Neurol; 2019 Aug; 61(8):972-978. PubMed ID: 30659594
[TBL] [Abstract][Full Text] [Related]
19. Surgical Treatment for Patients with Moyamoya Syndrome and Type 1 Neurofibromatosis.
Porras JL; Yang W; Garzon-Muvdi T; Xu R; Blakeley J; Belzberg A; Caplan JM; Khalid S; Colby GP; Coon AL; Tamargo RJ; Ahn ES; Huang J
World Neurosurg; 2017 Mar; 99():19-25. PubMed ID: 27876659
[TBL] [Abstract][Full Text] [Related]
20. Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children.
Descheemaeker MJ; Ghesquière P; Symons H; Fryns JP; Legius E
J Intellect Disabil Res; 2005 Jan; 49(Pt 1):33-46. PubMed ID: 15634310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
